Recurrence of a nasopharyngeal carcinoma manifesting as a cerebellopontine angle mass

Min Han Kong1, Jahendran Jeevanan, Thanabalan Jegan

  • 1Department of Otorhinolaryngology-Head and Neck Surgery, Pantai Cheras Medical Centre, 1 Jalan 1/96a, 56100 Cheras, Kuala Lumpur, Malaysia.

Ear, Nose, & Throat Journal
|December 25, 2013
PubMed

Insights

Nasopharyngeal carcinoma can extend into the brain, but rarely to the cerebellopontine angle. This case highlights a rare recurrence mimicking a benign tumor, emphasizing the need for vigilance in nasopharyngeal carcinoma patients.

Area of Science:

  • Neuro-oncology
  • Skull base surgery
  • Radiation oncology

Background:

  • Nasopharyngeal carcinoma (NPC) frequently presents with intracranial extension (31%).
  • Extension to the cerebellopontine angle (CPA) is an uncommon but serious complication.
  • Understanding the precise mechanisms of CPA spread in NPC is crucial for diagnosis and treatment.

Observation:

  • A 46-year-old woman with NPC, treated with chemoradiation and stereotactic radiosurgery, developed a CPA recurrence.
  • The recurrent tumor on magnetic resonance imaging (MRI) mimicked a benign lesion.
  • Histopathological diagnosis confirmed undifferentiated carcinoma of nasopharyngeal origin.

Findings:

  • The case illustrates a rare intracranial recurrence of NPC in the CPA one year after initial treatment.
  • The recurrence presented insidiously, resembling a benign tumor on imaging, complicating early detection.
  • Direct extension through the skull base, particularly the petrous apex and medial tentorial edge, is the presumed pathway.

Implications:

  • This case underscores the importance of considering NPC recurrence in the CPA, even with atypical imaging findings.
  • It highlights the challenges in differentiating NPC recurrence from other CPA masses.
  • Palliative chemotherapy was administered for the recurrent disease, indicating limited therapeutic options for advanced or recurrent intracranial NPC.